BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 23530560)

  • 1. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
    Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T
    Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer.
    Fujino K; Motooka Y; Hassan WA; Ali Abdalla MO; Sato Y; Kudoh S; Hasegawa K; Niimori-Kita K; Kobayashi H; Kubota I; Wakimoto J; Suzuki M; Ito T
    Am J Pathol; 2015 Dec; 185(12):3164-77. PubMed ID: 26482608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells.
    Kashiwagi K; Ishii J; Sakaeda M; Arimasu Y; Shimoyamada H; Sato H; Miyata C; Kamma H; Aoki I; Yazawa T
    Pathol Int; 2012 Apr; 62(4):232-45. PubMed ID: 22449227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.
    Ishii J; Sato H; Yazawa T; Shishido-Hara Y; Hiramatsu C; Nakatani Y; Kamma H
    Pathol Int; 2014 Sep; 64(9):415-22. PubMed ID: 25243889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
    Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
    Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural lineage-specific homeoprotein BRN2 is directly involved in TTF1 expression in small-cell lung cancer.
    Sakaeda M; Sato H; Ishii J; Miyata C; Kamma H; Shishido-Hara Y; Shimoyamada H; Fujiwara M; Endo T; Tanaka R; Kondo H; Goya T; Aoki I; Yazawa T
    Lab Invest; 2013 Apr; 93(4):408-21. PubMed ID: 23358112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of intermediate filament nestin in cell growth of small-cell lung cancer.
    Takakuwa O; Maeno K; Kunii E; Ozasa H; Hijikata H; Uemura T; Kasai D; Ohkubo H; Miyazaki M; Oguri T; Niimi A
    Lung Cancer; 2013 Aug; 81(2):174-9. PubMed ID: 23706418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
    Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
    Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
    Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T
    Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. System analysis identifies distinct and common functional networks governed by transcription factor ASCL1, in glioma and small cell lung cancer.
    Donakonda S; Sinha S; Dighe SN; Rao MRS
    Mol Biosyst; 2017 Jul; 13(8):1481-1494. PubMed ID: 28742165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
    Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
    Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
    Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
    Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells.
    Zhao H; Zhu L; Jin Y; Ji H; Yan X; Zhu X
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):177-82. PubMed ID: 22172490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
    Furuta M; Sakakibara-Konishi J; Kikuchi H; Yokouchi H; Nishihara H; Minemura H; Harada M; Yamazaki S; Akie K; Fujita Y; Takamura K; Kojima T; Harada T; Minami Y; Watanabe N; Oizumi S; Suzuki H; Nishimura M; Dosaka-Akita H; Isobe H;
    Oncologist; 2019 Nov; 24(11):e1172-e1179. PubMed ID: 31068386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers.
    Iida Y; Masuda S; Nakanishi Y; Shimizu T; Nishimaki H; Takahashi M; Hikichi M; Maruoka S; Gon Y; Takahashi N; Hashimoto S
    Hum Pathol; 2018 Sep; 79():127-134. PubMed ID: 29787820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.
    Borromeo MD; Savage TK; Kollipara RK; He M; Augustyn A; Osborne JK; Girard L; Minna JD; Gazdar AF; Cobb MH; Johnson JE
    Cell Rep; 2016 Aug; 16(5):1259-1272. PubMed ID: 27452466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells.
    Wang XD; Hu R; Ding Q; Savage TK; Huffman KE; Williams N; Cobb MH; Minna JD; Johnson JE; Yu Y
    Nat Commun; 2019 Jul; 10(1):3201. PubMed ID: 31324758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of the neural development transcription factors (TTF1, ASCL1 and BRN2) in neuroendocrine prostate tumours.
    Rodríguez-Zarco E; Vallejo-Benítez A; Umbría-Jiménez S; Pereira-Gallardo S; Pabón-Carrasco S; Azueta A; González-Cámpora R; Espinal PS; García-Escudero A
    Actas Urol Esp; 2017 Oct; 41(8):529-534. PubMed ID: 28285791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.
    Kelenis DP; Rodarte KE; Kollipara RK; Pozo K; Choudhuri SP; Spainhower KB; Wait SJ; Stastny V; Oliver TG; Johnson JE
    Cancer Res; 2022 Sep; 82(17):3058-3073. PubMed ID: 35748745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung.
    Nasgashio R; Sato Y; Matsumoto T; Kageyama T; Hattori M; Iyoda A; Satoh Y; Ryuge S; Masuda N; Jiang SX; Saegusa M
    Lung Cancer; 2011 Dec; 74(3):405-10. PubMed ID: 21601304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.